ESPE Abstracts (2014) 82 P-D-3-1-628

ESPE2014 Poster Category 3 Adrenals & HP Axis (13 abstracts)

Familial Glucocorticoid Deficiency: Masked Diagnosis by Hydrocortisone Life-Saving Treatment

Federico Baronio a , Angelica Marsigli a , Ilaria Bettocchi a , Davide Tassinari b , Laura Mazzanti a , Louise Metherell c & Antonio Balsamo a

aPediatric Unit, Department of Medical and Surgical Sciences, Program of Endocrinology, University of Bologna and
S.Orsola-Malpighi Hospital, Bologna, Italy; bEmergency Pediatric Unit, University of Bologna and S.Orsola Malpighi Hospital, Bologna, Italy; cWilliam Harvey Research Institute, Centre for Endocrinology, Queen Mary University of London, London, UK

Background: Familial glucocorticoid deficiency (FGD) is a rare and potentially life-threatening disease, characterized by adrenal insufficiency without mineralocorticoid deficiency. It is diagnosed during the neonatal period but also in childhood. Manifestations are recurrent hypoglycemia, seizures or even coma, chronic fatigue, recurrent infections and skin hyperpigmentation. Mutations on mineralocorticoid receptor 2 (MC2R) gene and on melanocortin-2 receptor accessory protein (MRAP) gene have been described in 25 and 15–20% of cases respectively.

Method: We report a girl, second child of (probably) related pakistani parents, with previous unremarkable pathological history She was evaluated at 2.3 years of age for severe drowsiness (GCS<8), ketotic hypoglycemia (1 mmol/l), hypotension, developed in course of febrile gastroenteritis. Hyperpigmentation was not recognized.

Euglycemia was restored with i.v. glucose and bolus of hydrocortisone. Cerebral infarction, poisoning, infectious encephalopathy, hyperinsulinism were excluded. Reduced serum cortisol (12 ng/ml) and ACTH levels were considered unreliable due to hydrocortisone treatment. Dexamethazone was early started for cerebral edema and continued for laryngeal edema, due to intubation. The child fully recovered and corticosteroid was tapered.

Results: The subsequent endocrine studies showed serum cortisol <2 ng/ml, ACTH >1250 pg/ml, with normal renin, aldosterone and electrolytes; FGD was suspected and the patient started regular treatment with hydrocortisone. Adrenal hypoplasia and Allgrove syndrome were excluded. Molecular analysis of MC2R gene showed a novel mutation (L283R) in homozygosis (confirmed in both parents).

Conclusion: Our case confirms that FGD is a rare cause of adrenal insufficiency in some cases triggered by infection. Corticosteroid treatment did not allow us to early reach the diagnosis, but saved the child. We suggest, in the case of pediatric ketotic hypoglycemia, to collect few ml of plasma for adrenal function evaluation, and then consider to promptly start corticosteroid treatment.

Article tools

My recent searches

No recent searches.